Empower your team to optimize medication use to drive better patient outcomes.
Sentri7 pharmacy surveillance technology integrates with the EHR to help pharmacists sift through a large volume of patient data to efficiently prioritize the most important opportunities for optimizing medication therapy.
-
Access an extensive evidence-based rule library created by our clinicians and updated continuously to reflect the latest regulations and science.
-
Optimize medication selection for cost containment and increase cost-effectiveness.
-
Dose and route optimization: manage renal dosing, Bayesian dosing, anticoagulation, IV-to-PO conversions, and high-risk medications in real time.
-
24/7 monitoring for adverse events
-
Sentri7 Analytics for a comprehensive view of Pharmacy, Antimicrobial Stewardship, and Opioid Stewardship through dashboards including Intervention documentation reporting, Pharmacy activity reporting, and NHSN benchmarking (SAAR).
-
SoleSource platform eases management and streamlines programs across facilities; standardize policies and procedures to drive continuous improvement.
Antimicrobial Use and Resistance Reporting
CMS has incorporated Antimicrobial Use and Resistance (AUR) reporting to National Health and Safety Network (NHSN) as a required element under the Public Health reporting category within Promoting Interoperability Program beginning in 2024. Talk to your Quality leader about the AUR reporting requirement to determine how to avoid penalties for non-reporting.
To qualify for the Promoting Interoperability program credit, AUR reports must be submitted to the NHSN by a vendor—like Sentri7® Pharmacy AMS—certified for AUR reporting by the ONC and listed on the Certified Health IT Product List (CHPL).
Since 2021, NHSN requires all production AU Summary Clinical Document Architecture (CDA) files contain an SDS Validation ID, which is provided by the NHSN to each vendor after successful validation. The same requirement has been in place for AR data beginning in May 2023.
Why customers choose Sentri 7 hospital pharmacy surveillance
Move the latest evidence-based guidance into practice.
Sentri7’s extensive content library contains hundreds of patient identification rules for medication management — manage renal dosing, anticoagulation, IV-to-PO conversions and high-risk medications over time. This turnkey content enables effective monitoring of medication use in accordance with hospital policies across patient populations, enabling pharmacy teams to quickly intervene and adjust therapies as needed. We continuously update the content to reflect the latest clinical and regulatory recommendations so it can be quickly adopted into practice to improve care.
Empowering
Designed by pharmacists. Controlled by you.
Evidence-based algorithms prioritize patients at greatest risk to improve care in real-time. Tailored workflows drive standardization and improve productivity. Teams can easily document actions to improve continuity of care across shifts and settings. One click pushes key intervention notes back to the EHR for enhanced communication. You can easily extend programs across facilities by adopting new rules within minutes – without the need for IT or vendor support.
Actionable insights
Transform data into insight. Optimize your impact on patient care.
Use our interactive Pharmacy Analytics dashboard to track key metrics and increase the pharmacy teams' impact on hospital- or system-level performance. The dashboard’s robust reports transform data into essential insights for revising policies or educating prescribers. Compare prescribed medications across facilities to ensure compliance with current health system priorities, identify high and low performers and track cost savings tied to interventions.
Featured insights for Medication Management
One nationally-recognized pediatric hospital relies on Sentri7’s turnkey evidence-based library to establish a set of rules and metrics to strengthen the pharmacy’s impact on the hospital’s key initiatives, including its antimicrobial stewardship program (ASP) and management of drug spend.
By standardizing pharmacy clinical practices, they achieved $1.2 million in hard cost-savings and saw a 123% increase in pharmacist dose evaluations. They reduced pharmacy spending through medication therapy adjustments, increased pharmacist dose evaluations and de-escalation of high-cost medications.